Weekly injectables like Ozempic and Wegovy are simpler to stick with
First, the GIP component may explain why tirzepatide produces comparable or even lower rates of nausea despite stronger weight loss
The term nonresponder refers to people who do not experience a meaningful benefit after an adequate dose and duration, and "meaningful" has a specific clinical definition: losing at least 5% of starting body weight, a threshold associated with health improvements
The label only mentions that Wegovy is not recommended in patients with severe gastroparesis. Gastroparesis should be treated seriously
This data allows PlexusDx to identify whether oral semaglutide, tirzepatide, or a dual-compound approach would deliver faster results tailored to your biology
In whole-cell voltage clamp experiments, excitatory postsynaptic currents (EPSCs) were measured at the membrane potential of 70 mV for 3 min